Clinical toxicology of exposures to chemicals from clandestine drug laboratories: a literature review

References

• Annual report 2019. In: International Narcotics Control Board UN, editor. Vienna. 2020. p. 102.
   Google Scholar
• Norman K, Ciesielski A, Wagner J. Identification and associated hazards of clandestine drug laboratories. WIREs Forensic Sci. 2021;3(3):e1393.
   Google Scholar
• Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances 2019. In: International Narcotics Control Board UN, editor. Vienna. 2021.
   Google Scholar
• enHealth Guidance on: Clandestine Drug Laboratories and Public Health Risks. Australian Department of Health; 2017.
   Google Scholar
• Martyny JW, Arbuckle SL, McCammon CS, Jr, et al. Chemical concentrations and contamination associated with clandestine methamphetamine laboratories. J Chem Health Saf. 2007;14(4):40–52.
   Google Scholar
• Person EC, Meyer JA, Vyvyan JR. Structural determination of the principal byproduct of the lithium-ammonia reduction method of methamphetamine manufacture. J Forensic Sci. 2005;50(1):87–95.
   PubMed Web of Science ®Google Scholar
• Brzeczko AW, Leech R, Stark JG. The advent of a new pseudoephedrine product to combat methamphetamine abuse. Am J Drug Alcohol Abuse. 2013;39(5):284–290.
   PubMed Web of Science ®Google Scholar
• Caldicott DG, Pigou PE, Beattie R, et al. Clandestine drug laboratories in Australia and the potential for harm. Aust N Z J Public Health. 2005;29(2):155–162.
   PubMed Web of Science ®Google Scholar
• Kuhn EJ, Walker GS, Whiley H, et al. Household contamination with methamphetamine: Knowledge and uncertainties. Int J Environ Res Public Health. 2019;16(23):4676.
   PubMed Web of Science ®Google Scholar
• Cooper D, Souther L, Hanlon D, et al. Public health consequences among first responders to emergency events associated with illicit methamphetamine laboratories – selected states, 1996–1999. MMWR Morb Mortal Wkly Rep. 2000;49(45):1021–1024.
   PubMedGoogle Scholar
• Cooper D, Rice N, Wilburn R, et al. Acute public health consequences of methamphetamine laboratories – 16 states, january 2000–june 2004. MMWR Morb Mortal Wkly Rep. 2005;54(14):356–359.
   PubMedGoogle Scholar
• Arant T, Henry C, Clifford W, et al. Anhydrous ammonia thefts and releases associated with illicit methamphetamine production – 16 states, january 2000–june 2004. MMWR Morb Mortal Wkly Rep. 2005;54(14):359–361.
   PubMedGoogle Scholar
• Melnikova N, Welles WL, Wilburn RE, et al. Hazards of illicit methamphetamine production and efforts at reduction: data from the hazardous substances emergency events surveillance system. Public Health Rep. 2011;126(Suppl 1):116–123.
   PubMed Web of Science ®Google Scholar
• Melnikova N, Orr M, Wu J, et al. Injuries from Methamphetamine-Related chemical Incidents - Five states, 2001-2012. MMWR Morb Mortal Wkly Rep. 2015;64(33):909–912.
   PubMed Web of Science ®Google Scholar
• Horton D, Berkowitz Z, Kaye W. The acute health consequences to children exposed to hazardous substances used in illicit methamphetamine production, 1996 to 2001. J Children’s Health. 2003;1(1):99–108.
   Google Scholar
• Lee JH, Farley CL, Brodrick CD, et al. Anhydrous ammonia eye injuries associated with illicit methamphetamine production. Ann Emerg Med. 2003;41(1):157.
   PubMed Web of Science ®Google Scholar
• Chan A, Storck S, Stone D. Ocular injuries from shake and bake methamphetamine labs. J Oklahoma State Med Assoc. 2009;104:11–12.
   Google Scholar
• Dhaliwal K, Sood A. Ammonia inhalational lung injury during illicit methamphetamine production. J Burns Surg Wound Care. 2003;2:15.
   Google Scholar
• Bloom GR, Suhail F, Hopkins-Price P, et al. Acute anhydrous ammonia injury from accidents during illicit methamphetamine production. Burns. 2008;34(5):713–718.
   PubMed Web of Science ®Google Scholar
• Willers-Russo LJ. Three fatalities involving phosphine gas, produced as a result of methamphetamine manufacturing. J Forensic Sci. 1999;44(3):647–652.
   PubMed Web of Science ®Google Scholar
• Phosphine Results - AEGLProgram: U.S. Environmental Protection Agency | US EPA. Available from: https://www.epa.gov/aegl/phosphine-results-aeglprogram
   Google Scholar
• Wheeler T, Griffin L. Phosphine linked to two deaths at clandestine methamphetamine lab. J Clandesine Laboratory Investigating Chemists Assoc. 1997;7(4):8.
   Google Scholar
• Burgess J, Burgess J. Phosphine exposure from a methamphetamine laboratory investigation. J Toxicol Clin Toxicol. 2001;39(2):165–168.
   PubMed Web of Science ®Google Scholar
• Thrasher DL, Von Derau K, Burgess J. Health effects from reported exposure to methamphetamine labs: a poison center-based study. J Med Toxicol. 2009;5(4):200–204.
   PubMedGoogle Scholar
• Horton DK, Orr M, Tsongas T, et al. Secondary contamination of medical personnel, equipment, and facilities resulting from hazardous materials events, 2003-2006. Disaster Med Public Health Prep. 2008;2(2):104–113.
   PubMed Web of Science ®Google Scholar
• Wright J, Kenneally ME, Edwards JW, et al. Adverse health effects associated with living in a former methamphetamine drug Laboratory - Victoria, Australia, 2015. MMWR Morb Mortal Wkly Rep. 2017;65(52):1470–1473.
   PubMed Web of Science ®Google Scholar
• Ligeiro de Oliveira AP, Lino-dos-Santos-Franco A, Acceturi BG, et al. Long-term amphetamine treatment exacerbates inflammatory lung reaction while decreases airway hyper-responsiveness after allergic stimulus in rats. Int Immunopharmacol. 2012;14(4):523–529.
   PubMed Web of Science ®Google Scholar
• Tsai H, Lee J, Hedlin H, et al. Methamphetamine use association with pulmonary diseases: a retrospective investigation of hospital discharges in California from 2005 to 2011. ERJ Open Res. 2019;5(4):00017-2019.
   PubMedGoogle Scholar
• Burgess JL, Barnhart S, Checkoway H. Investigating clandestine drug laboratories: adverse medical effects in law enforcement personnel. Am J Ind Med. 1996;30(4):488–494.
   PubMed Web of Science ®Google Scholar
• Burgess JL, Kovalchick DF, Siegel EM, et al. Medical surveillance of clandestine drug laboratory investigators. J Occup Environ Med. 2002;44(2):184–189.
   PubMed Web of Science ®Google Scholar
• Witter RZ, Martyny JW, Mueller K, et al. Symptoms experienced by law enforcement personnel during methamphetamine lab investigations. J Occup Environ Hyg. 2007;4(12):895–902.
   PubMed Web of Science ®Google Scholar
• Farst KD, Moss M, Ray RM, et al. Methamphetamine exposure presenting as caustic ingestions in children. Ann Emerg Med. 2007;49(3):341–343.
   PubMed Web of Science ®Google Scholar
• Burge M, Hunsaker J, 3rd, Davis G. Death of a toddler due to ingestion of sulfuric acid at a clandestine home methamphetamine laboratory. Forensic Sci Med Pathol. 2009;5(4):298–301.
   PubMed Web of Science ®Google Scholar
• Manning T. Drug labs and endangered children. FBI Law Enforcement Bulletin. 1999;68(7):10–15.
   Google Scholar
• Horton DK, Berkowitz Z, Kaye WE. Secondary contamination of ED personnel from hazardous materials events, 1995-2001. Am J Emerg Med. 2003;21(3):199–204.
   PubMed Web of Science ®Google Scholar
• Toxicological profile for ammonia. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 2004.
   Google Scholar
• Chahid Y, Dormans T, Theunissen P, et al. Intoxicatie na inname van precursors van amfetamine. Pharmaceutisch Weekblad. 2010;4(11|12):3.
   Google Scholar
• Brown H, Pollard KA. Drugs of abuse: Sympathomimetics. Crit Care Clin. 2021;37(3):487–499.
   PubMed Web of Science ®Google Scholar
• Malay ME. Unintentional methamphetamine intoxication. J Emerg Nurs. 2001;27(1):13–16.
   PubMedGoogle Scholar
• Wijnands-Kleukers APG, Dijkman W, Brogtrop J, et al. Inhalational methanol intoxication: Emerging issues in The Netherlands resulting from illegal drug production. Ann Emerg Med. 2019;74(5):727–728.
   PubMed Web of Science ®Google Scholar
• Wijnands-Kleukers APG, Sikma MA, Dijkman W, et al. Abstract 340. Beware of inhalatory methanol poisoning in illegal drug production. 39th international congress of the european association of poisons centres and clinical toxicologists (EAPCCT) 21-24 may 2019, Naples, Italy. Clin Toxicol (Phila). 2019;57(6):580.
   Google Scholar
• Bruckner JV, Anand SS. Chapter 24 - Toxic effects of solvents and vapors. In: Klaassen CD, Watkins JB, editors. Casarett & doull’s essentials of toxicology. 3rd ed. New York: The McGraw-Hill Companies, Inc.; 2015.
   Google Scholar
• Sciuto AM, Wong BJ, Martens ME, et al. Phosphine toxicity: a story of disrupted mitochondrial metabolism. Ann N Y Acad Sci. 2016;1374(1):41–51.
   PubMed Web of Science ®Google Scholar
• Anjaria M, Evans H. Cook’ fails chem 101: hydrogen sulfide fatality. J Clan Lab Invest Chem Assoc. 2003;7:5–10.
   Google Scholar
• Ng PC, Hendry-Hofer TB, Witeof AE, et al. Hydrogen sulfide toxicity: Mechanism of action, clinical presentation, and countermeasure development. J Med Toxicol. 2019;15(4):287–294.
   PubMed Web of Science ®Google Scholar
• World Drug Report 2020 - Booklet 2. United Nations Office on Drugs and Crime - Division for Policy Analysis and Public Affairs; 2020.
   Google Scholar
• Xu Q, Boggio A, Ballabeni A. Countries' biomedical publications and attraction scores. A PubMed-based assessment. F1000Res. 2014;3:292.
   PubMedGoogle Scholar